BIA Separations announced that the European Patent Office confirmed the revocation of European Patent 0765183B1 owned by GE Healthcare, stating that the patent’s technology was anticipated by prior art. Novasep Process signed a partnership agreement with Proxcys Downstream Biosystems BV to develop products for the downstream processing of biomolecules. Under a collaboration agreement announced in […]
Molecular Sensing exclusively licensed Vanderbilt University’s technology for a biosensor platform based on backscattering interferometry. ForteBio named Joseph D. Keegan, PhD, former president and CEO of Molecular Devices, president and CEO in September. NextGen Sciences named Dr. Mike Pisano, founder of Proteomic Research Services (see IBO 1/31/07), CEO. Precision System Science reported fiscal 2007 sales […]
Santa Clara, CA 10/24/07; San Diego, CA 10/125/07—Affymetrix announced that it has filed new patent lawsuits against Illumina in the US, the UK and Germany, alleging infringement of eight patents. Three of the US patents (Patent Nos. 5,902,723, 6,403,320, and 6,576,424) and the three EU Patents (Patent Nos. 0834575, 0853679 and 0799897) relate to Illumina’s […]
Affymetrix and Partners Healthcare extended their translational research collaboration (see IBO 12/15/06) with a contract array manufacturing supply agreement. Affymetrix and IPSOGEN will collaborate to develop and market in vitro diagnostic tests. Empire Genomics, a molecular karyotyping platform technology company, licensed a number of Affymetrix’s patents covering the manufacturing, use and sales of microarrays and […]
For companies in the instrument industry, protecting patents is a crucial aspect of business. As was the case in last year’s article (see IBO 11/30/06), Bio-Rad, Applied Biosystems and Invitrogen continue to be among the most legally aggressive companies. First, to begin on a positive note, Bio-Rad’s suit against 4titude and Phenix Research Products was […]
Foster City, CA and Santa Clara, CA 9/18/07—Applera, Applied Biosystems’ parent company, and Agilent Technologies have entered a settlement agreement, resolving Applera’s patent infringement suits in multiple countries against Stratagene, which Agilent acquired in June (see IBO 4/15/07). Agilent agreed to license certain Applera technology for real-time thermal cycler instruments in research-related fields, excluding human […]
Foster City, CA 9/7/07; New York, NY 9/7/07—-Applied Biosystems announced that the US District Court for the District of Connecticut granted its motion for summary judgment and dismissed all remaining claims in the patent infringement case brought by Enzo Biochem against Applera, Applied Biosystems’ parent company. In the lawsuit, filed in 2004, Enzo Biochem, Enzo […]
In May, Affymetrix opened a manufacturing facility in Singapore. ChannelNewsAsia reports that the facility will manufacture 30% of the company’s products and has a staff of 124. Affymetrix appointed John C. Batty CFO and executive vice president in June. He previously served as senior vice president of finance and CFO of Credence Systems. In July, […]
In March, Enzo Biochem announced that the US Board of Patents and Interferences entered judgment in its favor for its patent application for nucleic acid signal amplification over two Princeton University patents. The Chido Companies, owner of Clean Air Labs, established a strategic partnership with Roche Diagnostics to set a DNA-based standard for mold detection […]
Syrris opened an office in La Jolla, California. Biotage AB elected Axel Broms and Per-Olof Eriksson to its Board, replacing Jeff Bork and Björn Odlander. In May, Agilent and Integrated DNA Technologies agreed to harmonize their chemistry, processes and analytical techniques and to provide reciprocal referrals for synthetic oligonucleotides, creating a complete development pathway for […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
